UPDATE: Citi Upgrades Novavax (NVAX) to Buy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/25/2026

1. NVDA
2. SPY
3. AAPL
4. XPEV
5. USO
6. BMO
7. VEEV
8. DKS
9. AMD
10. MU

October 31, 2017 6:17 AM EDT
Get Alerts NVAX Hot Sheet
Price: $9.44 +6.55%

Rating Summary:
    10 Buy, 3 Hold, 5 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 8 | Down: 10 | New: 18
Join SI Premium – FREE
(Updated - October 31, 2017 6:21 AM EDT)

(updated to add analyst comment)

Citi upgraded Novavax (NASDAQ: NVAX) from Neutral to Buy with a price target of $1.60 (from $1.10).

Analyst Joel Beatty believes the market is overlooking the NT flu vaccine catalysts which he believes represents a strong market opportunity as superior flu vaccines are in demand.

For an analyst ratings summary and ratings history on Novavax click here. For more ratings news on Novavax click here.

Shares of Novavax closed at $1.02 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst PT Change, Hot Upgrades, Upgrades

Related Entities

Citi